Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure
- 1 September 1997
- journal article
- briefcommunication
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 12 (9) , 563-566
- https://doi.org/10.1046/j.1525-1497.1997.07110.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failureJournal of General Internal Medicine, 1997
- Factors contributing to the hospitalization of patients with congestive heart failure.American Journal of Public Health, 1997
- Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitalsThe American Journal of Cardiology, 1996
- Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: Clinical characteristics and drug therapyThe American Journal of Medicine, 1995
- Guidelines for the Evaluation and Management of Heart FailureJournal of the American College of Cardiology, 1995
- Patterns of Medication Use in Patients With Heart FailureSouthern Medical Journal, 1995
- Perspective of the pharmaceutical industry on the development of new drugs for heart failureJournal of the American College of Cardiology, 1993
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsNew England Journal of Medicine, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991